Interestingly, from the mid-1980s onwards, it has repeatedly been shown that the brain not only responds to local injury or infection with increased production of IL-1, but also during systemic inflammation induced by the intravenous or intraperitoneal administration of bacterial LPS [58,59,60,61,62]. This evidence concerns the gene IL1B and infection.